CordovaCann (LVRLF) Income from Continuing Operations (2017 - 2020)
CordovaCann (LVRLF) recorded quarterly Income from Continuing Operations of 77278.41 in Q1 2020, up 94.58% quarter-over-quarter from 1426641.98 in Q2 2019, and up 91.98% on a YoY basis from 40252.35 in Q2 2019.
CordovaCann (LVRLF) Income from Continuing Operations (2017 - 2020) Analysis & Trends
CordovaCann's Income from Continuing Operations history runs 4 years deep, the most recent figure standing at 77278.41 for Q1 2020.
- In Q1 2020, Income from Continuing Operations rose 91.98% year-over-year to 77278.41; the TTM figure through Mar 2020 stood at 3716146.06 (down 8.5% YoY), while the FY2025 annual figure was 1552796.33, down 105.08% from the prior year.
- Income from Continuing Operations was 77278.41 for Q1 2020 at CordovaCann, up from 1426641.98 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 15834.13 in Q1 2017 to a low of 2649253.64 in Q1 2018.
- Historically, Income from Continuing Operations has averaged 949247.65 across 4 years, with a median of 824408.59 in 2018.
- The sharpest annual moves came in 2018 and 2020: Income from Continuing Operations tumbled 16631.29% in 2018, then soared 91.98% in 2020.
- A 4-year view of Income from Continuing Operations shows it stood at 15834.13 in 2017, then plunged by 7782.16% to 1248071.78 in 2018, then retreated by 14.31% to 1426641.98 in 2019, then jumped by 94.58% to 77278.41 in 2020.
- The last three Income from Continuing Operations figures came in at 77278.41 (Q1 2020), 1426641.98 (Q2 2019), and 964153.89 (Q1 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -92.12 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 118.42 Mn |
| 10 | CordovaCann | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | -77,278.41 |
| Jun 30, 2019 | -1.43 Mn |
| Mar 31, 2019 | -964,153.89 |
| Dec 31, 2018 | -1.25 Mn |
| Sep 30, 2018 | -684,663.29 |
| Jun 30, 2018 | -528,084.05 |
| Mar 31, 2018 | -2.65 Mn |
| Mar 31, 2017 | -15,834.13 |